Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...
pharmacy benefit managers, and high drug prices to make health care more affordable for Hoosiers.” That political backdrop coincides with other challenges. Late last year, Elevance endured a ...
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...
Elevance Health (NYSE: ELV) presented at the Barclays ... identify members with care gaps and chronic risk factors. Our care management teams then perform proactive outreach to provide early ...
In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these ...
GreensKeeper Asset Management stated the following regarding Elevance Health, Inc. (NYSE ... utilizing the company's digital solutions to improve care quality for consumers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback